BACKGROUNDAgreement • April 6th, 2000 • Tanox Inc • Services-medical laboratories • California
EXHIBIT 10.13 CERTAIN INFORMATION IN THIS EXHIBIT IS SUBJECT TO A REQUEST FOR CONFIDENTIAL TREATMENT. IN ACCORDANCE WITH RULE 406 UNDER THE SECURITIES ACT OF 1933, AS AMENDED, SUCH INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES...License Agreement • February 11th, 2000 • Tanox Inc • Services-medical laboratories • Massachusetts
RECITALSIndemnification Agreement • March 9th, 2000 • Tanox Inc • Services-medical laboratories • Delaware
ANDLease Agreement • March 9th, 2000 • Tanox Inc • Services-medical laboratories • Texas
EXHIBIT 10.6 STOCK PURCHASE AGREEMENT THIS STOCK PURCHASE AGREEMENT is made as of the 14th day of July, 1987, by and between TANOX BIOSYSTEMS, INC., a Texas corporation (the "company") , TSE WEN CHANG, NANCY T. CHANG and ALAFI CAPITAL COMPANY, a...Stock Purchase Agreement • March 9th, 2000 • Tanox Inc • Services-medical laboratories • Texas
RECITALSMaster Agreement • April 6th, 2000 • Tanox Inc • Services-medical laboratories • California
UNDERWRITING AGREEMENTUnderwriting Agreement • April 6th, 2000 • Tanox Inc • Services-medical laboratories • New York
EXHIBIT 4.2 THIS WARRANT HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. NO SALE OR DISPOSITION MAY BE EFFECTED WITHOUT (i) AN EFFECTIVE REGISTRATION STATEMENT RELATED THERETO, (ii) AN OPINION OF COUNSEL FOR THE HOLDER,...Tanox Inc • March 9th, 2000 • Services-medical laboratories • Texas
BACKGROUNDVoting Agreement • March 9th, 2000 • Tanox Inc • Services-medical laboratories • Texas
TANOX, INC. ANDRights Agreement • August 3rd, 2001 • Tanox Inc • Pharmaceutical preparations • Delaware
BACKGROUNDAgreement • February 11th, 2000 • Tanox Inc • Services-medical laboratories • California
LICENSE FOR WINTER PATENTTanox Inc • February 11th, 2000 • Services-medical laboratories
BACKGROUNDNon-Exclusive License Agreement • February 11th, 2000 • Tanox Inc • Services-medical laboratories • Washington
EXHIBIT 10.13 CERTAIN INFORMATION IN THIS EXHIBIT IS SUBJECT TO A REQUEST FOR CONFIDENTIAL TREATMENT. IN ACCORDANCE WITH RULE 406 UNDER THE SECURITIES ACT OF 1933, AS AMENDED, SUCH INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES...License Agreement • April 6th, 2000 • Tanox Inc • Services-medical laboratories • Massachusetts
RECITALS:Development and Licensing Agreement • April 6th, 2000 • Tanox Inc • Services-medical laboratories • Texas
Exhibit 10.28 ADDENDUM X TO THE LEASE AGREEMENT BY AND BETWEEN MAIN LINK BUSINESS PARK ASSOCIATES ("Landlord") AND TANOX, INC. (f/k/a Tanox Biosvstems. Inc.) ------------------------------------------ ("Tenant")The Lease Agreement • March 11th, 2002 • Tanox Inc • Pharmaceutical preparations
BACKGROUNDNon-Exclusive License Agreement • April 6th, 2000 • Tanox Inc • Services-medical laboratories • Washington
BETWEENResearch and Licence Agreement • March 9th, 2000 • Tanox Inc • Services-medical laboratories
AGREEMENT AND PLAN OF MERGER BY AND AMONG GENENTECH, INC. GREEN ACQUISITION CORPORATION and TANOX, INC. Dated as of November 9, 2006Agreement and Plan of Merger • March 16th, 2007 • Tanox Inc • Pharmaceutical preparations • Delaware
THIS AGREEMENT AND PLAN OF MERGER is made and entered into as of November 9, 2006 (the “Agreement”), by and among Genentech, Inc., a Delaware corporation (“Parent”), Green Acquisition Corporation, a Delaware corporation and a wholly-owned subsidiary of Parent (“Merger Sub”), and Tanox, Inc., a Delaware corporation (the “Company”).
EXHIBIT 10.16 SETTLEMENT AND CROSS-LICENSING AGREEMENT This Settlement and Cross-Licensing Agreement ("Agreement") is entered into effective as of July 8, 1996 ("Effective Date") between Tanox Biosystems, Inc., a Texas corporation, with its principal...Settlement and Cross-Licensing Agreement • April 6th, 2000 • Tanox Inc • Services-medical laboratories • Texas
CONFIDENTIAL TANOX BIOSYSTEMS, INC. SUPPLEMENTAL AGREEMENT Tanox and Ciba currently are engaged in settling certain litigation with Genentech and Roche. In connection with the settlement of such litigation, Tanox, Ciba and Genentech (and possibly...Agreement • April 6th, 2000 • Tanox Inc • Services-medical laboratories
ASSET PURCHASE AND LICENSE AGREEMENTAsset Purchase and License Agreement • May 5th, 2005 • Tanox Inc • Pharmaceutical preparations • Delaware
This Asset Purchase and License Agreement (this “Agreement”), dated the 25th day of March, 2005 (the “Effective Date”), is by and among Sunol Molecular Corporation, a Delaware corporation having its principal offices at 2810 North Commerce Parkway, Miramar, Florida 33025-3958 (“Seller”), Tanox, Inc., a Delaware corporation having its principal offices at 10301 Stella Link, Houston, Texas 77025 (“Purchaser”), and solely with respect to the Sections and Articles hereof set forth in Section 15.14 below, Altor Bioscience Corporation, a Delaware corporation having its principal offices at 2810 North Commerce Parkway, Miramar, Florida 33025-3958 (“Altor”).
TANOX, INC. NON-QUALIFIED STOCK OPTION AGREEMENTNon-Qualified Stock Option Agreement • March 10th, 2005 • Tanox Inc • Pharmaceutical preparations • Texas
FORM OF VOTING AGREEMENTForm of Voting Agreement • November 16th, 2006 • Tanox Inc • Pharmaceutical preparations • Delaware
THIS VOTING AGREEMENT (this “Agreement”) is made and entered into as of November 9, 2006, by and between Genentech, Inc., a Delaware corporation (“Parent”) and the undersigned stockholder (“Stockholder”) of Tanox, Inc. (the “Company”).
TRIPARTITE COOPERATION AGREEMENT By and Between NOVARTIS PHARMA AG GENENTECH, INC. AND TANOX, INC. Dated as of February 25, 2004Tripartite Cooperation Agreement • May 10th, 2004 • Tanox Inc • Pharmaceutical preparations • New York
CONFIDENTIAL TANOX BIOSYSTEMS INC.Settlement and Participation Agreement • April 6th, 2000 • Tanox Inc • Services-medical laboratories • New York
AMENDED AND RESTATED DEVELOPMENT AND LICENSING AGREEMENTDevelopment and Licensing Agreement • May 10th, 2004 • Tanox Inc • Pharmaceutical preparations • New York
This Amended and Restated Development and Licensing Agreement (“Agreement”) is made and entered into as of the 25th day of February, 2004 (the “Effective Date”), between Tanox, Inc. (formerly known as Tanox Biosystems, Inc.), originally a Texas corporation and reincorporated as a Delaware corporation (“Tanox”), and Novartis Pharma AG, a company organized and existing under the laws of Switzerland (as successor-in-interest of Ciba-Geigy Limited) (“Novartis”). (Each of Novartis and Tanox is referred to herein individually as a “Party” and all are referred to collectively herein as the “Parties.”)
STOCKHOLDER AND REGISTRATION RIGHTS AGREEMENTStockholder and Registration Rights Agreement • May 27th, 2005 • Tanox Inc • Pharmaceutical preparations • Delaware
This STOCKHOLDER AND REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of March 31, 2005, by and among Tanox, Inc., a Delaware corporation (the “Company”), Sunol Molecular Corporation, a Delaware corporation (the “Seller”), and the parties identified on the signature page of this Agreement (collectively, the “Initial Holders”).
AMENDMENT TO RIGHTS AGREEMENTRights Agreement • November 16th, 2006 • Tanox Inc • Pharmaceutical preparations • Delaware
This Amendment to Rights Agreement (this “Amendment”), dated as of November 9, 2006, between Tanox, Inc., a Delaware corporation (the “Company”), and American Stock Transfer & Trust Company, a New York corporation, as Rights Agent (the “Rights Agent”), amends that certain Rights Agreement, dated as of July 27, 2001 (the “Rights Agreement”).
FOURTH LEASE AMENDMENT AND ASSIGNMENT AGREEMENTFourth Lease Amendment and Assignment Agreement • March 10th, 2005 • Tanox Inc • Pharmaceutical preparations • California
This Fourth Lease Amendment and Assignment Agreement (the “Agreement”), dated for references purposes as of December 9, 2004, is entered into by and among TSI, L.P., a California limited partnership (“TSI” or “Landlord”); Biogen Idec Inc., a Delaware corporation formerly known as IDEC Pharmaceuticals Corporation (“BI”); and Tanox West, Inc., a Delaware corporation (“Tanox West”), with reference to the following facts:
DateTanox Inc • June 8th, 2000 • Services-medical laboratories • Texas
EMPLOYMENT AGREEMENTEmployment Agreement • November 8th, 2006 • Tanox Inc • Pharmaceutical preparations
THIS EMPLOYMENT AGREEMENT (“Agreement”) is dated as of Sept. 12, 2006, by and between TANOX, INC. (the “Company”) and NANCY T. CHANG, PhD. (“Dr. Chang”);
TANOX, INC. NON-QUALIFIED STOCK OPTION AGREEMENTNon-Qualified Stock Option Agreement • March 10th, 2005 • Tanox Inc • Pharmaceutical preparations • Texas
LEASE ASSIGNMENT AND ASSET PURCHASE AGREEMENTLease Assignment and Asset Purchase Agreement • March 10th, 2005 • Tanox Inc • Pharmaceutical preparations • California
THIS LEASE ASSIGNMENT AND ASSET PURCHASE AGREEMENT (this “Agreement”) is made and effective on December 9, 2004 by and between TANOX WEST, INC., a Delaware corporation (“Purchaser” or “Tanox West”) and BIOGEN IDEC INC., a Delaware corporation (“Seller”), with reference to the facts set forth in the Recitals below:
CREDIT AGREEMENTCredit Agreement • November 7th, 2002 • Tanox Inc • Pharmaceutical preparations • Texas
THIS AGREEMENT is entered into as of September 27, 2002, by and between TANOX, INC. a Delaware corporation (“Borrower”), and WELLS FARGO BANK TEXAS, NATIONAL ASSOCIATION (“Bank”).
